August 25, 2023
A large, international study in patients undergoing non-cardiac thoracic surgery found that the anti-inflammatory drug, colchicine, did not significantly reduce...
Read More
August 18, 2023
More than $6.1 million has been awarded in total to PHRI studies in the Spring 2023 project grant competition of...
Read More
August 14, 2023
In an interview during the European Stroke Organisation Conference (ESOC 2023) in Munich, Germany, PHRI Scientist Ashkan Shoamanesh, in a video...
Read More
August 11, 2023
A strong line-up of racialized women working in health equity research during the COVID pandemic will lecture at a new...
Read More
August 10, 2023
PHRI participated in the Joint Statistical Meetings (JSM 2023) August 5 – 10 in Toronto – the largest gathering of...
Read More
July 26, 2023
Polypills, aka fixed dose combination (FDC) therapy, have been added for the first time to the 2023 Essential Medicines List...
Read MoreBack To Top
